[Skip to Navigation]
Editorial
March 2016

Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy

Author Affiliations
  • 1Departments of Neurology, Anesthesiology, and Surgery, University of Massachusetts Medical School, Worcester
  • 2Departments of Neurology, Anesthesiology, and Surgery, UMass Memorial Medical Center, Worcester, Massachusetts
JAMA Neurol. 2016;73(3):265-267. doi:10.1001/jamaneurol.2015.4453
Add or change institution
×